Medical device maker Beyond Air up on promising data from lung device study

Beyond Air

17/10/2022 22:30

** Medical device maker Beyond Air Inc's shares  XAIR.O  up
3.4% at $6.02 after market
    ** Company says its medical device, LungFit GO, to treat
patients with lung diseases caused by nontuberculous
mycobacteria, showed a lower microbial load in an at-home pilot
study  urn:newsml:reuters.com:*:nGNX55FDgN
    ** As of last close, company's shares down ~36% YTD
 (Reporting by Khushi Mandowara)
 ((Khushi.Mandowara@thomsonreuters.com))